{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T18:46:24Z","timestamp":1775673984708,"version":"3.50.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"14","license":[{"start":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T00:00:00Z","timestamp":1736899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T00:00:00Z","timestamp":1736899200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81902905"],"award-info":[{"award-number":["81902905"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Guangzhou Basic and Applied Basic Research Foundation 385"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2025,4,18]]},"DOI":"10.1038\/s41388-024-03272-1","type":"journal-article","created":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T11:17:01Z","timestamp":1736939821000},"page":"983-995","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Pyrithione zinc alters mismatch repair to trigger tumor immunogenicity"],"prefix":"10.1038","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-1194-1188","authenticated-orcid":false,"given":"Huanling","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaxin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiantian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huan","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunyuan","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0087-2453","authenticated-orcid":false,"given":"Zining","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,15]]},"reference":[{"key":"3272_CR1","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1200\/JCO.2010.32.2537","volume":"29","author":"PF Robbins","year":"2011","unstructured":"Robbins PF, Morgan RA, Feldman SA, Yang JC, Sherry RM, Dudley ME, et al. Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1. J Clin Oncol. 2011;29:917\u201324.","journal-title":"J Clin Oncol"},{"key":"3272_CR2","doi-asserted-by":"publisher","first-page":"3044","DOI":"10.3390\/curroncol29050247","volume":"29","author":"Y Shiravand","year":"2022","unstructured":"Shiravand Y, Khodadadi F, Kashani SMA, Hosseini-Fard SR, Hosseini S, Sadeghirad H, et al. Immune checkpoint inhibitors in cancer therapy. Curr Oncol. 2022;29:3044\u201360.","journal-title":"Curr Oncol"},{"key":"3272_CR3","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1586\/era.09.88","volume":"9","author":"AP De Souza","year":"2009","unstructured":"De Souza AP, Bonorino C. Tumor immunosuppressive environment: effects on tumor-specific and nontumor antigen immune responses. Expert Rev Anticancer Ther. 2009;9:1317\u201332.","journal-title":"Expert Rev Anticancer Ther"},{"key":"3272_CR4","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.semcancer.2019.07.017","volume":"65","author":"R Saleh","year":"2020","unstructured":"Saleh R, Elkord E. Acquired resistance to cancer immunotherapy: role of tumor-mediated immunosuppression. Semin Cancer Biol. 2020;65:13\u201327.","journal-title":"Semin Cancer Biol"},{"key":"3272_CR5","doi-asserted-by":"publisher","first-page":"5516","DOI":"10.1039\/D0BM01183E","volume":"8","author":"OT Shofolawe-Bakare","year":"2020","unstructured":"Shofolawe-Bakare OT, Stokes LD, Hossain M, Smith AE, Werfel TA. Immunostimulatory biomaterials to boost tumor immunogenicity. Biomater Sci. 2020;8:5516\u201337.","journal-title":"Biomater Sci"},{"key":"3272_CR6","doi-asserted-by":"publisher","first-page":"4850","DOI":"10.1172\/JCI127471","volume":"129","author":"Z Wang","year":"2019","unstructured":"Wang Z, Chen J, Hu J, Zhang H, Xu F, He W, et al. cGAS\/STING axis mediates a topoisomerase II inhibitor-induced tumor immunogenicity. J Clin Investig. 2019;129:4850\u201362.","journal-title":"J Clin Investig"},{"key":"3272_CR7","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.cell.2018.06.026","volume":"174","author":"W Zhou","year":"2018","unstructured":"Zhou W, Whiteley AT, de Oliveira Mann CC, Morehouse BR, Nowak RP, Fischer ES, et al. Structure of the human cGAS-DNA complex reveals enhanced control of immune surveillance. Cell. 2018;174:300\u201311.e311.","journal-title":"Cell"},{"key":"3272_CR8","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1146\/annurev-biochem-061516-044813","volume":"86","author":"K Kato","year":"2017","unstructured":"Kato K, Omura H, Ishitani R, Nureki O. Cyclic GMP-AMP as an endogenous second messenger in innate immune signaling by cytosolic DNA. Annu Rev Biochem. 2017;86:541\u201366.","journal-title":"Annu Rev Biochem"},{"key":"3272_CR9","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1038\/nature08476","volume":"461","author":"H Ishikawa","year":"2009","unstructured":"Ishikawa H, Ma Z, Barber GN. STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity. Nature. 2009;461:788\u201392.","journal-title":"Nature"},{"key":"3272_CR10","doi-asserted-by":"publisher","DOI":"10.15252\/embr.201846935","volume":"19","author":"LT Khoo","year":"2018","unstructured":"Khoo LT, Chen LY. Role of the cGAS-STING pathway in cancer development and oncotherapeutic approaches. EMBO Rep. 2018;19:e46935.","journal-title":"EMBO Rep"},{"key":"3272_CR11","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/s41586-019-0998-5","volume":"567","author":"G Shang","year":"2019","unstructured":"Shang G, Zhang C, Chen ZJ, Bai XC, Zhang X. Cryo-EM structures of STING reveal its mechanism of activation by cyclic GMP-AMP. Nature. 2019;567:389\u201393.","journal-title":"Nature"},{"key":"3272_CR12","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.immuni.2014.10.017","volume":"41","author":"SR Woo","year":"2014","unstructured":"Woo SR, Fuertes MB, Corrales L, Spranger S, Furdyna MJ, Leung MY, et al. STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors. Immunity. 2014;41:830\u201342.","journal-title":"Immunity"},{"key":"3272_CR13","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1038\/s43018-022-00497-5","volume":"3","author":"E Alouani","year":"2022","unstructured":"Alouani E, Rousseau B, Andre T, Marabelle A. Immunotherapy advances in cancers with mismatch repair or proofreading deficiencies. Nat Cancer. 2022;3:1414\u20137.","journal-title":"Nat Cancer"},{"key":"3272_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2020.188447","volume":"1874","author":"DY Lizardo","year":"2020","unstructured":"Lizardo DY, Kuang C, Hao S, Yu J, Huang Y, Zhang L. Immunotherapy efficacy on mismatch repair-deficient colorectal cancer: from bench to bedside. Biochim Biophys Acta Rev Cancer. 2020;1874:188447.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"3272_CR15","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1097\/PAI.0000000000001089","volume":"31","author":"Q Huang","year":"2023","unstructured":"Huang Q, Yu T, Li L, Zhang Q, Zhang S, Li B, et al. Intraindividual tumor heterogeneity of mismatch repair status in metastatic colorectal cancer. Appl Immunohistochem Mol Morphol. 2023;31:84\u201393.","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"3272_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13915-7","volume":"11","author":"K Von Loga","year":"2020","unstructured":"Von Loga K, Woolston A, Punta M, Barber LJ, Griffiths B, Semiannikova M, et al. Extreme intratumour heterogeneity and driver evolution in mismatch repair deficient gastro-oesophageal cancer. Nat Commun. 2020;11:139.","journal-title":"Nat Commun"},{"key":"3272_CR17","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.ccell.2022.12.003","volume":"41","author":"V Amodio","year":"2023","unstructured":"Amodio V, Lamba S, Chila R, Cattaneo CM, Mussolin B, Corti G, et al. Genetic and pharmacological modulation of DNA mismatch repair heterogeneous tumors promotes immune surveillance. Cancer Cell. 2023;41:196\u2013209.e195.","journal-title":"Cancer Cell"},{"key":"3272_CR18","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1158\/2159-8290.CD-21-1434","volume":"12","author":"G Crisafulli","year":"2022","unstructured":"Crisafulli G, Sartore-Bianchi A, Lazzari L, Pietrantonio F, Amatu A, Macagno M, et al. Temozolomide treatment alters mismatch repair and boosts mutational burden in tumor and blood of colorectal cancer patients. Cancer Discov. 2022;12:1656\u201375.","journal-title":"Cancer Discov"},{"key":"3272_CR19","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/nature24673","volume":"552","author":"G Germano","year":"2017","unstructured":"Germano G, Lamba S, Rospo G, Barault L, Magri A, Maione F, et al. Inactivation of DNA repair triggers neoantigen generation and impairs tumour growth. Nature. 2017;552:116\u201320.","journal-title":"Nature"},{"key":"3272_CR20","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.ccell.2020.11.004","volume":"39","author":"J Guan","year":"2021","unstructured":"Guan J, Lu C, Jin Q, Lu H, Chen X, Tian L, et al. MLH1 deficiency-triggered DNA hyperexcision by exonuclease 1 activates the cGAS-STING pathway. Cancer Cell. 2021;39:109\u201321.e105.","journal-title":"Cancer Cell"},{"key":"3272_CR21","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.ccell.2020.11.006","volume":"39","author":"C Lu","year":"2021","unstructured":"Lu C, Guan J, Lu S, Jin Q, Rousseau B, Lu T, et al. DNA sensing in mismatch repair-deficient tumor cells is essential for anti-tumor immunity. Cancer Cell. 2021;39:96\u2013108.e106.","journal-title":"Cancer Cell"},{"key":"3272_CR22","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/s41420-022-01046-w","volume":"8","author":"M Yan","year":"2022","unstructured":"Yan M, Li Y, Luo Q, Zeng W, Shao X, Li L, et al. Mitochondrial damage and activation of the cytosolic DNA sensor cGAS-STING pathway lead to cardiac pyroptosis and hypertrophy in diabetic cardiomyopathy mice. Cell Death Discov. 2022;8:258.","journal-title":"Cell Death Discov"},{"key":"3272_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.828657","volume":"9","author":"R Shen","year":"2021","unstructured":"Shen R, Liu D, Wang X, Guo Z, Sun H, Song Y, et al. DNA damage and activation of cGAS\/STING pathway induce tumor microenvironment remodeling. Front Cell Dev Biol. 2021;9:828657.","journal-title":"Front Cell Dev Biol"},{"key":"3272_CR24","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1111\/php.13100","volume":"95","author":"L Sandiford","year":"2019","unstructured":"Sandiford L, Holmes AM, Mangion SE, Mohammed YH, Zvyagin AV, Roberts MS. Optical characterization of zinc pyrithione. Photochem Photobiol. 2019;95:1142\u201350.","journal-title":"Photochem Photobiol"},{"key":"3272_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-30588-2","volume":"8","author":"M Park","year":"2018","unstructured":"Park M, Cho YJ, Lee YW, Jung WH. Understanding the mechanism of action of the anti-dandruff agent zinc pyrithione against Malassezia restricta. Sci Rep. 2018;8:12086.","journal-title":"Sci Rep"},{"key":"3272_CR26","doi-asserted-by":"publisher","first-page":"3536","DOI":"10.1038\/onc.2011.521","volume":"31","author":"M Tailler","year":"2012","unstructured":"Tailler M, Senovilla L, Lainey E, Thepot S, Metivier D, Sebert M, et al. Antineoplastic activity of ouabain and pyrithione zinc in acute myeloid leukemia. Oncogene. 2012;31:3536\u201346.","journal-title":"Oncogene"},{"key":"3272_CR27","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.ecoenv.2018.06.026","volume":"161","author":"JZ Mo","year":"2018","unstructured":"Mo JZ, Lin DR, Wang JZ, Li P, Liu WH. Apoptosis in HepG2 cells induced by zinc pyrithione via mitochondrial dysfunction pathway: involvement of zinc accumulation and oxidative stress. Ecotox Environ Saf. 2018;161:515\u201325.","journal-title":"Ecotox Environ Saf"},{"key":"3272_CR28","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1016\/j.molonc.2015.05.005","volume":"9","author":"G Srivastava","year":"2015","unstructured":"Srivastava G, Matta A, Fu GD, Somasundaram RT, Datti A, Walfish PG, et al. Anticancer activity of pyrithione zinc in oral cancer cells identified in small molecule screens and xenograft model: Implications for oral cancer therapy. Mol Oncol. 2015;9:1720\u201335.","journal-title":"Mol Oncol"},{"key":"3272_CR29","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s10534-010-9302-8","volume":"23","author":"E Rudolf","year":"2010","unstructured":"Rudolf E, Cervinka M. Zinc pyrithione induces cellular stress signaling and apoptosis in Hep-2 cervical tumor cells: the role of mitochondria and lysosomes. Biometals. 2010;23:339\u201354.","journal-title":"Biometals"},{"key":"3272_CR30","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.1080\/14756366.2022.2108417","volume":"37","author":"J Kladnik","year":"2022","unstructured":"Kladnik J, Dolinar A, Kljun J, Perea D, Grau-Exposito J, Genesca M, et al. Zinc pyrithione is a potent inhibitor of PL(Pro) and cathepsin L enzymes with ex vivo inhibition of SARS-CoV-2 entry and replication. J Enzyme Inhib Med Chem. 2022;37:2158\u201368.","journal-title":"J Enzyme Inhib Med Chem"},{"key":"3272_CR31","doi-asserted-by":"publisher","first-page":"C1088","DOI":"10.1152\/ajpcell.00070.2021","volume":"320","author":"EE Figueroa","year":"2021","unstructured":"Figueroa EE, Denton JS. Zinc pyrithione activates the volume-regulated anion channel through an antioxidant-sensitive mechanism. Am J Physiol Cell Physiol. 2021;320:C1088\u201398.","journal-title":"Am J Physiol Cell Physiol"},{"key":"3272_CR32","doi-asserted-by":"publisher","first-page":"91","DOI":"10.4196\/kjpp.2010.14.2.91","volume":"14","author":"YS Cho","year":"2010","unstructured":"Cho YS, Lee KH, Park JW. Pyrithione-zinc prevents UVB-induced epidermal hyperplasia by inducing HIF-1alpha. Korean J Physiol Pharmacol. 2010;14:91\u20137.","journal-title":"Korean J Physiol Pharmacol"},{"key":"3272_CR33","doi-asserted-by":"publisher","first-page":"e002155","DOI":"10.1136\/jitc-2020-002155","volume":"9","author":"Z Wang","year":"2021","unstructured":"Wang Z, Xu F, Hu J, Zhang H, Cui L, Lu W, et al. Modulation of lactate-lysosome axis in dendritic cells by clotrimazole potentiates antitumor immunity. J Immunother Cancer. 2021;9:e002155.","journal-title":"J Immunother Cancer"},{"key":"3272_CR34","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.dnarep.2015.11.019","volume":"38","author":"Z Li","year":"2016","unstructured":"Li Z, Pearlman AH, Hsieh P. DNA mismatch repair and the DNA damage response. DNA Repair. 2016;38:94\u2013101.","journal-title":"DNA Repair"},{"key":"3272_CR35","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.molcel.2005.02.015","volume":"17","author":"M Koshiji","year":"2005","unstructured":"Koshiji M, To KK, Hammer S, Kumamoto K, Harris AL, Modrich P, et al. HIF-1alpha induces genetic instability by transcriptionally downregulating MutSalpha expression. Mol Cell. 2005;17:793\u2013803.","journal-title":"Mol Cell"},{"key":"3272_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-49740-8","volume":"13","author":"HN Oh","year":"2023","unstructured":"Oh HN, Kim WK. Copper pyrithione and zinc pyrithione induce cytotoxicity and neurotoxicity in neuronal\/astrocytic co-cultured cells via oxidative stress. Sci Rep. 2023;13:23060.","journal-title":"Sci Rep"},{"key":"3272_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2018.101084","volume":"25","author":"US Srinivas","year":"2019","unstructured":"Srinivas US, Tan BWQ, Vellayappan BA, Jeyasekharan AD. ROS and the DNA damage response in cancer. Redox Biol. 2019;25:101084.","journal-title":"Redox Biol"},{"key":"3272_CR38","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s00018-022-04219-z","volume":"79","author":"RR Yu","year":"2022","unstructured":"Yu RR, Zhu B, Chen DG. Type I interferon-mediated tumor immunity and its role in immunotherapy. Cell Mol Life Sci. 2022;79:191.","journal-title":"Cell Mol Life Sci"},{"key":"3272_CR39","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/s12276-023-00965-7","volume":"55","author":"J Kim","year":"2023","unstructured":"Kim J, Kim HS, Chung JH. Molecular mechanisms of mitochondrial DNA release and activation of the cGAS-STING pathway. Exp Mol Med. 2023;55:510\u20139.","journal-title":"Exp Mol Med"},{"key":"3272_CR40","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.49020","volume":"8","author":"S Wang","year":"2019","unstructured":"Wang S, He Z, Wang X, Li H, Liu XS. Antigen presentation and tumor immunogenicity in cancer immunotherapy response prediction. eLife. 2019;8:e49020.","journal-title":"eLife"},{"key":"3272_CR41","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.critrevonc.2016.10.010","volume":"108","author":"A Drean","year":"2016","unstructured":"Drean A, Lord CJ, Ashworth A. PARP inhibitor combination therapy. Crit Rev Oncol Hematol. 2016;108:73\u201385.","journal-title":"Crit Rev Oncol Hematol"},{"key":"3272_CR42","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1186\/s13046-022-02469-0","volume":"41","author":"C Shi","year":"2022","unstructured":"Shi C, Qin K, Lin A, Jiang A, Cheng Q, Liu Z, et al. The role of DNA damage repair (DDR) system in response to immune checkpoint inhibitor (ICI) therapy. J Exp Clin Cancer Res. 2022;41:268.","journal-title":"J Exp Clin Cancer Res"},{"key":"3272_CR43","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1126\/science.aan6733","volume":"357","author":"DT Le","year":"2017","unstructured":"Le DT, Durham JN, Smith KN, Wang H, Bartlett BR, Aulakh LK, et al. Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade. Science. 2017;357:409\u201313.","journal-title":"Science"},{"key":"3272_CR44","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1016\/j.jtho.2019.05.014","volume":"14","author":"S Park","year":"2019","unstructured":"Park S, Lee H, Lee B, Lee SH, Sun JM, Park WY, et al. DNA damage response and repair pathway alteration and its association with tumor mutation burden and platinum-based chemotherapy in SCLC. J Thorac Oncol. 2019;14:1640\u201350.","journal-title":"J Thorac Oncol"},{"key":"3272_CR45","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1126\/science.aau0447","volume":"364","author":"R Mandal","year":"2019","unstructured":"Mandal R, Samstein RM, Lee KW, Havel JJ, Wang H, Krishna C, et al. Genetic diversity of tumors with mismatch repair deficiency influences anti-PD-1 immunotherapy response. Science. 2019;364:485\u201391.","journal-title":"Science"},{"key":"3272_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.795972","volume":"13","author":"X Zhang","year":"2022","unstructured":"Zhang X, Wu T, Cai X, Dong J, Xia C, Zhou Y, et al. Neoadjuvant immunotherapy for MSI-H\/dMMR locally advanced colorectal cancer: new strategies and unveiled opportunities. Front Immunol. 2022;13:795972.","journal-title":"Front Immunol"},{"key":"3272_CR47","first-page":"2585","volume":"6","author":"HS Friedman","year":"2000","unstructured":"Friedman HS, Kerby T, Calvert H. Temozolomide and treatment of malignant glioma. Clin Cancer Res. 2000;6:2585\u201397.","journal-title":"Clin Cancer Res"},{"key":"3272_CR48","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1093\/neuonc\/noy072","volume":"20","author":"A Karachi","year":"2018","unstructured":"Karachi A, Dastmalchi F, Mitchell DA, Rahman M. Temozolomide for immunomodulation in the treatment of glioblastoma. Neuro Oncol. 2018;20:1566\u201372.","journal-title":"Neuro Oncol"},{"key":"3272_CR49","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1200\/JCO.21.02583","volume":"40","author":"F Morano","year":"2022","unstructured":"Morano F, Raimondi A, Pagani F, Lonardi S, Salvatore L, Cremolini C, et al. Temozolomide followed by combination with low-dose ipilimumab and nivolumab in patients with microsatellite-stable, O(6)-methylguanine-DNA methyltransferase-silenced metastatic colorectal cancer: the MAYA trial. J Clin Oncol. 2022;40:1562\u201373.","journal-title":"J Clin Oncol"},{"key":"3272_CR50","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.celrep.2015.03.041","volume":"11","author":"YJ Shen","year":"2015","unstructured":"Shen YJ, Le Bert N, Chitre AA, Koo CX, Nga XH, Ho SS, et al. Genome-derived cytosolic DNA mediates type I interferon-dependent rejection of B cell lymphoma cells. Cell Rep. 2015;11:460\u201373.","journal-title":"Cell Rep"},{"key":"3272_CR51","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/nature14156","volume":"520","author":"AP West","year":"2015","unstructured":"West AP, Khoury-Hanold W, Staron M, Tal MC, Pineda CM, Lang SM, et al. Mitochondrial DNA stress primes the antiviral innate immune response. Nature. 2015;520:553\u20137.","journal-title":"Nature"},{"key":"3272_CR52","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2222\/jsv.58.37","volume":"58","author":"A Takaoka","year":"2008","unstructured":"Takaoka A, Shinohara S. DNA sensors in innate immune system. Uirusu. 2008;58:37\u201346.","journal-title":"Uirusu"},{"key":"3272_CR53","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.3390\/cancers13112695","volume":"13","author":"A Amouzegar","year":"2021","unstructured":"Amouzegar A, Chelvanambi M, Filderman JN, Storkus WJ, Luke JJ. STING agonists as cancer therapeutics. Cancers. 2021;13:2695.","journal-title":"Cancers"},{"key":"3272_CR54","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1038\/s43018-022-00468-w","volume":"3","author":"N Samson","year":"2022","unstructured":"Samson N, Ablasser A. The cGAS-STING pathway and cancer. Nat Cancer. 2022;3:1452\u201363.","journal-title":"Nat Cancer"},{"key":"3272_CR55","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/nri3845","volume":"15","author":"L Zitvogel","year":"2015","unstructured":"Zitvogel L, Galluzzi L, Kepp O, Smyth MJ, Kroemer G. Type I interferons in anticancer immunity. Nat Rev Immunol. 2015;15:405\u201314.","journal-title":"Nat Rev Immunol"},{"key":"3272_CR56","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1124\/mol.106.027029","volume":"70","author":"Q Ke","year":"2006","unstructured":"Ke Q, Costa M. Hypoxia-inducible factor-1 (HIF-1). Mol Pharmacol. 2006;70:1469\u201380.","journal-title":"Mol Pharmacol"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-024-03272-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-024-03272-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-024-03272-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T08:58:37Z","timestamp":1743411517000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-024-03272-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,15]]},"references-count":56,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2025,4,18]]}},"alternative-id":["3272"],"URL":"https:\/\/doi.org\/10.1038\/s41388-024-03272-1","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,15]]},"assertion":[{"value":"24 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All methods used in the present study were in accordance with the relevant guidelines and regulations. All animal procedures were reviewed and approved by the Institutional Animal Care and Use Committee of Sun Yat-sen University. Informed consent was obtained from all the participants. This work does not involve human research.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}